Askleia
French tech company | Builders Republic
About
Maker of continuous purification technology for biopharmaceutical manufacturing — replacing traditional column-based separation with two platforms: the Y Series, which precipitates and filters out contaminants on the fly, and the F Series, a chip that separates molecules using an electric field.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2021
- City
- AUBAGNE
- Region
- Provence-Alpes-Côte d’Azur
- Tracked rounds
- 1
- Amount raised
- 2.3 M€ raised since 2020
Funding rounds
- Seed — 2026